<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02174120</url>
  </required_header>
  <id_info>
    <org_study_id>20140623</org_study_id>
    <nct_id>NCT02174120</nct_id>
  </id_info>
  <brief_title>The Application of Target Controlled Infusion of Etomidate Combined With Propofol in the Maintenance of Anesthesia During Brain Surgeries</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Henan Provincial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Henan Provincial Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To explore the application of target controlled infusion of etomidate combined with propofol
      in the maintenance of anesthesia during brain surgeries.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">September 2015</completion_date>
  <primary_completion_date type="Anticipated">September 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Heart rate</measure>
    <time_frame>Baseline to the end of the operation, expected to be about 6 h</time_frame>
    <description>Heart rate should be recorded before induction, 1 min, 5 min, 20 min after intubation, at the time of skin incision, skull drilling, incision of dura matter, during intracranial operation, suture of dura matter and skin.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>Baseline to the end of the operation, expected to be about 6 h</time_frame>
    <description>Blood pressure should be recorded before induction, 1 min, 5 min, 20 min after intubation, at the time of skin incision, skull drilling, incision of dura matter, during intracranial operation, suture of dura matter and skin.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Concentration of cortisol</measure>
    <time_frame>from baseline to the end of the operation, expected to be about 6 h</time_frame>
    <description>Concentration of cortisol should be recorded before induction, 30 min, 1 h, 2 h after intubation, and immediately when the operation is over.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Use of vasoactive agent</measure>
    <time_frame>from the beginning of induction to the end of the operation, expected to be about 6 h</time_frame>
    <description>The name and dose of the vasoactive agents used from the beginning of induction to the end of operation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The time from stop of remifentanil to awake</measure>
    <time_frame>The time from stop of remifentanil to awake, expected to no more than 15 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severity of agitation</measure>
    <time_frame>Within 24 h after the operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative nausea and vomiting</measure>
    <time_frame>Within 24 h after the operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dose of etomidate and propofol</measure>
    <time_frame>From the beginning of induction to the end of the operation, expected to be about 6 h</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative awareness</measure>
    <time_frame>From the beginning of induction to the end of the operation, expected to be about 6 h</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Expense of anesthetics</measure>
    <time_frame>From the beginning of induction to the end of the operation, expected to be about 6 h</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Allergic reaction</measure>
    <time_frame>From beginning of induction to 24 h after the operation</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Target Controlled Infusion</condition>
  <condition>General Anesthesia</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>During maintenance of anesthesia, etomidate was give by target controlled infusion, the effect-site concentration is 0.3 to 0.6 micrograms/ml to keep bispectral index between 40 to 60.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>During maintenance of anesthesia, Propofol was give by target controlled infusion, the effect-site concentration is 2 to 4 micrograms/ml to keep bispectral index between 40 to 60.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>During maintenance of anesthesia, etomidate will be given by target controlled infusion for 2 h first, and then propofol will be given by target controlled infusion, the effect-site concentration is 0.3 to 0.6 micrograms/ml and 2 to 4 micrograms/ml, respectively. Bispectral index should be kept between 40 to 60.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>propofol</intervention_name>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>etomidate</intervention_name>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
    <other_name>Fu Er Li</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged between 60 and 80 years Brain surgeries Body weight is between 45 to 75 kg and
             body mass index is no more than 30 kg/m2 American Society of Anesthesiology (ASA)
             Physical Status: Ⅰ or Ⅱ Expected operation duration is between 3 and 5 h Signed
             informed consent form

        Exclusion Criteria:

          -  Serious cardiac, cerebral(acute stroke, uncontrolled seizure, sever dementia), liver,
             kidney, lung, endocrine disease or sepsis History of general anesthesia within 24 h
             before the operation Long use of hormone or history of adrenal suppression
             Hyperlipidaemia Long use of psychotropic substances Systolic pressure is still under
             90 mm Hg after twice given of vasopressor agent Suspected abuse of narcotic analgesia
             Patients need to use neuromuscular blocking drugs (except intubation) Allergy to trial
             drug or other contraindication Pregnant or breast-feeding women Attendance of other
             trial past 30 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 24, 2014</study_first_submitted>
  <study_first_submitted_qc>June 24, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 25, 2014</study_first_posted>
  <last_update_submitted>June 24, 2014</last_update_submitted>
  <last_update_submitted_qc>June 24, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 25, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Henan Provincial Hospital</investigator_affiliation>
    <investigator_full_name>Liu He</investigator_full_name>
    <investigator_title>Physician</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Etomidate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

